Pathological Tau Disrupts Ongoing Network Activity

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · see citing works

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · see citing works

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · see citing works

A novel slow (< 1 Hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components

Steriade, M., Nunez, A., & Amzica, F. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03252.1993 · Cited by 1,903 · see citing works

Dynamics of ongoing activity: explanation of the large variability in evoked cortical responses

Arieli, A., Sterkin, A., Grinvald, A., & Aertsen, A. (1996) · Science · doi:10.1126/science.273.5283.1868 · Cited by 1,660 · see citing works

Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration

Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118 · see citing works

Role of tau protein in both physiological and pathological conditions

AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · see citing works

Neocortical Network Activity<i>In Vivo</i>Is Generated through a Dynamic Balance of Excitation and Inhibition

Haider, B., Duque, A., Hasenstaub, A. R., & McCormick, D. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5297-05.2006 · Cited by 962 · see citing works

Sleep spindles: an overview

Gennaro, L. D., & Ferrara, M. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0252 · Cited by 925 · see citing works

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

Stamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885 · see citing works

Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex

Cowan, R. L., & Wilson, C. J. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.71.1.17 · Cited by 535 · see citing works

Synaptic background activity influences spatiotemporal integration in single pyramidal cells.

Bernander, Ö., Douglas, R. J., Martin, K. A. C., & Koch, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11569 · Cited by 518 · see citing works

The role of tau in neurodegeneration

Gendron, T. F., & Petrucelli, L. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-13 · Cited by 478 · see citing works

Region-specific Dissociation of Neuronal Loss and Neurofibrillary Pathology in a Mouse Model of Tauopathy

Spires, T. L., Orne, J. D., SantaCruz, K., Pitstick, R., Carlson, G. A., Ashe, K. H., & Hyman, B. T. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050840 · Cited by 401 · see citing works

Axonal transport defects: a common theme in neurodegenerative diseases

Roy, S., Zhang, B., Lee, V. M. ‐., & Trojanowski, J. Q. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0952-x · Cited by 372 · see citing works

Spontaneous Subthreshold Membrane Potential Fluctuations and Action Potential Variability of Rat Corticostriatal and Striatal Neurons In Vivo

Stern, E. A., Kincaid, A. E., & Wilson, C. J. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.4.1697 · Cited by 362 · see citing works

Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1

Thies, E., & Mandelkow, E.-M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4674-06.2007 · Cited by 293 · see citing works

Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains

Hof, P. R. (2000) · Elsevier eBooks · Cited by 289 · see citing works

Inhibition Determines Membrane Potential Dynamics and Controls Action Potential Generation in Awake and Sleeping Cat Cortex

Rudolph, M., Pospischil, M., Timofeev, I., & Destexhe, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4652-06.2007 · Cited by 247 · see citing works

Properties of Slow Oscillation during Slow-Wave Sleep and Anesthesia in Cats

Chauvette, S., Crochet, S., Volgushev, M., & Timofeev, I. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2339-11.2011 · Cited by 227 · see citing works

Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo

Kuchibhotla, K. V., Wegmann, S., Kopeikina, K. J., Hawkes, J., Rudinskiy, N., Andermann, M. L., Spires-Jones, T. L., Bacskai, B. J., & Hyman, B. T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318807111 · Cited by 193 · see citing works

Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs

Rocher, A. B., Crimins, J. L., Amatrudo, J. M., Kinson, M. S., Todd-Brown, M. A., Lewis, J., & Luebke, J. I. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.029 · Cited by 187 · see citing works

Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy

Crimins, J. L., Rocher, A. B., & Luebke, J. I. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1038-9 · Cited by 137 · see citing works

Synaptic alterations in the rTg4510 mouse model of tauopathy

Kopeikina, K. J., Polydoro, M., Tai, H., Yaeger, E., Carlson, G. A., Pitstick, R., Hyman, B. T., & Spires‐Jones, T. L. (2012) · The Journal of Comparative Neurology · doi:10.1002/cne.23234 · Cited by 125 · see citing works

Synaptic Integration in Rat Frontal Cortex Shaped by Network Activity

Léger, J., Stern, E. A., Aertsen, A., & Heck, D. H. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00067.2003 · Cited by 114 · see citing works

Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis

Oh, K.-J., Perez, S. E., Lagalwar, S., Vana, L., Binder, L., & Mufson, E. J. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/780102 · Cited by 105 · see citing works

Tau‐Induced Traffic Jams Reflect Organelles Accumulation at Points of Microtubule Polar Mismatching

Shemesh, O. A., Erez, H., Ginzburg, I., & Spira, M. E. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00695.x · Cited by 72 · see citing works

Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy

Crimins, J. L., Rocher, A. B., Peters, A., Shultz, P. L., Lewis, J. M., & Luebke, J. I. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0877-0 · Cited by 71 · see citing works

Age-dependent effects of microglial inhibition in vivo on Alzheimer’s disease neuropathology using bioactive-conjugated iron oxide nanoparticles

Glat, M. J., Skaat, H., Menkes-Caspi, N., Margel, S., & Stern, E. A. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-32 · Cited by 54 · see citing works

Alzheimer disease

Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606 · see citing works

The Cellular Phase of Alzheimer’s Disease

De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · see citing works

Synergy between amyloid-β and tau in Alzheimer’s disease

Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242 · see citing works

PET Imaging of Tau Deposition in the Aging Human Brain

Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214 · see citing works

Sleep and Human Aging

Mander, B. A., Winer, J. R., & Walker, M. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.004 · Cited by 1,214 · see citing works

Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease

Bejanin, A., Schonhaut, D. R., La Joie, R., Kramer, J. H., Baker, S. L., Sosa, N., Ayakta, N., Cantwell, A., Janabi, M., Lauriola, M., et al. (2017) · Brain · doi:10.1093/brain/awx243 · Cited by 778 · see citing works

Synaptic degeneration in Alzheimer disease

Tzioras, M., McGeachan, R. I., Durrant, C. S., & Spires-Jones, T. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00749-z · Cited by 504 · see citing works

Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?

Mander, B. A., Winer, J. R., Jagust, W. J., & Walker, M. P. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.05.002 · Cited by 467 · see citing works

Tau association with synaptic vesicles causes presynaptic dysfunction

Zhou, L., McInnes, J., Wierda, K., Holt, M., Herrmann, A. G., Jackson, R. J., Wang, Y.-C., Swerts, J., Beyens, J., Miskiewicz, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms15295 · Cited by 434 · see citing works

Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo

Busche, M. A., Wegmann, S., Dujardin, S., Commins, C., Schiantarelli, J., Klickstein, N., Kamath, T. V., Carlson, G. A., Nelken, I., & Hyman, B. T. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0289-8 · Cited by 413 · see citing works

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

the Synaptic Health Endpoints Working Group, Colom-Cadena, M., Spires-Jones, T., Zetterberg, H., Blennow, K., Caggiano, A., DeKosky, S. T., Fillit, H., Harrison, J. E., Schneider, L. S., et al. (2020) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-020-00588-4 · Cited by 328 · see citing works

Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging

Ossenkoppele, R., Smith, R., Mattsson-Carlgren, N., Groot, C., Leuzy, A., Strandberg, O., Palmqvist, S., Olsson, T., Jögi, J., Stormrud, E., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.1858 · Cited by 311 · see citing works

Aging and Alzheimer's disease: comparison and associations from molecular to system level

Xia, X., Jiang, Q., McDermott, J., & Han, J. J. (2018) · Aging Cell · doi:10.1111/acel.12802 · Cited by 301 · see citing works

Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease

Otero-Garcia, M., Mahajani, S. U., Wakhloo, D., Tang, W., Xue, Y.-Q., Morabito, S., Pan, J., Oberhauser, J., Madira, A. E., Shakouri, T., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.021 · Cited by 262 · see citing works

Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain

Winer, J. R., Mander, B. A., Helfrich, R. F., Maaß, A., Harrison, T. M., Baker, S. L., Knight, R. T., Jagust, W. J., & Walker, M. P. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0503-19.2019 · Cited by 259 · see citing works

Alzheimer’s Disease: From Firing Instability to Homeostasis Network Collapse

Frère, S. G. A., & Slutsky, I. (2018) · Neuron · doi:10.1016/j.neuron.2017.11.028 · Cited by 230 · see citing works

Analyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities

Dorostkar, M. M., Zou, C., Blazquez-Llorca, L., & Herms, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1449-5 · Cited by 235 · see citing works

Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease

Cedernaes, J., Osorio, R. S., Varga, A. W., Kam, K., Schiöth, H. B., & Benedict, C. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.02.002 · Cited by 200 · see citing works

Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression

Meftah, S., & Gan, J. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1129036 · Cited by 197 · see citing works

Updates on mouse models of Alzheimer’s disease

Zhong, M. Z., Peng, T., Duarte, M. L., Wang, M., & Cai, D. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00712-0 · Cited by 189 · see citing works

Caspase-2 cleavage of tau reversibly impairs memory

Zhao, X., Kotilinek, L. A., Smith, B., Hlynialuk, C., Zahs, K., Ramsden, M., Cleary, J., & Ashe, K. H. (2016) · Nature Medicine · doi:10.1038/nm.4199 · Cited by 187 · see citing works

Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer’s Disease

Pickett, E. K., Herrmann, A. G., McQueen, J., Abt, K., Dando, O., Tulloch, J., Jain, P., Dunnett, S., Sohrabi, S., Fjeldstad, M. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.044 · Cited by 179 · see citing works

Networks of tau distribution in Alzheimer’s disease

Hoenig, M. C., Bischof, G. N., Seemiller, J., Hammes, J., Kukolja, J., Onur, O. A., Jessen, F., Fließbach, K., Neumaier, B., Fink, G. R., et al. (2017) · Brain · doi:10.1093/brain/awx353 · Cited by 174 · see citing works

Shaping the Default Activity Pattern of the Cortical Network

Sanchez-Vives, M. V., Massimini, M., & Mattia, M. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.015 · Cited by 167 · see citing works

Tipping the Scales: Peptide-Dependent Dysregulation of Neural Circuit Dynamics in Alzheimer’s Disease

Harris, S. S., Wolf, F., De Strooper, B., & Busche, M. A. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.005 · Cited by 161 · see citing works

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

Swarup, V., Hinz, F. I., Rexach, J. E., Noguchi, K.-I., Toyoshiba, H., Oda, A., Hirai, K., Sarkar, A., Seyfried, N. T., Cheng, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0223-3 · Cited by 136 · see citing works

Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment

Hatch, R. J., Yan, W., Xia, D., & Götz, J. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1674-1 · Cited by 147 · see citing works

Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: An integrative review

Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 146 · see citing works

Neuronal Network Excitability in Alzheimer’s Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau

Kazim, S. F., Seo, J. H., Bianchi, R., Larson, C. S., Sharma, A., Wong, R. K. S., Gorbachev, K., & Pereira, A. C. (2021) · eNeuro · doi:10.1523/eneuro.0418-20.2020 · Cited by 113 · see citing works

Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau

Rayaprolu, S., Higginbotham, L., Bagchi, P., Watson, C. M., Zhang, T., Levey, A. I., Rangaraju, S., & Seyfried, N. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00840-3 · Cited by 118 · see citing works

Human tau increases amyloid β plaque size but not amyloid β‐mediated synapse loss in a novel mouse model of Alzheimer's disease

Jackson, R. J., Rudinskiy, N., Herrmann, A. G., Croft, S., Kim, J. M., Petrova, V., Ramos‐Rodríguez, J. J., Pitstick, R., Wegmann, S., Garcı́a-Alloza, M., et al. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13442 · Cited by 109 · see citing works

Neurophysiological signatures in Alzheimer’s disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline

Ranasinghe, K. G., Cha, J., Iaccarino, L., Hinkley, L. B. N., Beagle, A. J., Pham, J. Q., Jagust, W. J., Miller, B. L., Rankin, K. P., Rabinovici, G. D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4069 · Cited by 106 · see citing works

Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain

Ossenkoppele, R., Iaccarino, L., Schonhaut, D. R., Brown, J. A., Joie, R. L., O’Neil, J. P., Janabi, M., Baker, S. L., Kramer, J. H., Gorno‐Tempini, M., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101848 · Cited by 103 · see citing works

Synaptic activity and Alzheimer's disease: a critical update

Tampellini, D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00423 · Cited by 105 · see citing works

Cortex-wide BOLD fMRI activity reflects locally-recorded slow oscillation-associated calcium waves

Schwalm, M., Schmid, F., Wachsmuth, L., Backhaus, H., Kronfeld, A., Aedo-Jury, F., Prouvot, P.-H., Fois, C., Albers, F., van Alst, T. M., et al. (2017) · eLife · doi:10.7554/elife.27602 · Cited by 101 · see citing works

Is the glymphatic system the missing link between sleep impairments and neurological disorders? Examining the implications and uncertainties

Christensen, J., Yamakawa, G. R., Shultz, S. R., & Mychasiuk, R. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101917 · Cited by 105 · see citing works

How Can Insulin Resistance Cause Alzheimer’s Disease?

Yoon, J. H., Hwang, J., Son, S. U., Choi, J., You, S.-W., Park, H., Cha, S.-Y., & Maeng, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043506 · Cited by 104 · see citing works

In vivo tau pathology is associated with synaptic loss and altered synaptic function

Coomans, E. M., Schoonhoven, D. N., Tuncel, H., Verfaillie, S. C. J., Wolters, E. E., Boellaard, R., Ossenkoppele, R., den Braber, A., Scheper, W., Schober, P. R., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00772-0 · Cited by 101 · see citing works

Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology

Ahnaou, A., Moechars, D., Raeymaekers, L., Biermans, R., Manyakov, N. V., Bottelbergs, A., Wintmolders, C., Van Kolen, K., Van De Casteele, T., Kemp, J. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13839-6 · Cited by 98 · see citing works

Local Sleep and Alzheimer’s Disease Pathophysiology

Mander, B. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.525970 · Cited by 97 · see citing works

Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks

Hansson, O., Grothe, M. J., Strandberg, T. O., Ohlsson, T. G., Hägerström, D., Jögi, J., Smith, R. A., & Schöll, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00167 · Cited by 98 · see citing works

A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy

Hernández, I., Luna, G., Rauch, J. N., Reis, S. A., Giroux, M., Karch, C. M. M., Boctor, D., Sibih, Y., Storm, N. J., Díaz, A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat3005 · Cited by 95 · see citing works

Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease

Toniolo, S., Sen, A., & Husain, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239318 · Cited by 94 · see citing works

Predicting diagnosis and cognition with ¹⁸ F‐AV‐1451 tau PET and structural MRI in Alzheimer's disease

Mattsson, N., Insel, P. S., Donohue, M., Jögi, J., Ossenkoppele, R., Olsson, T., Schöll, M., Smith, R., & Hansson, O. (2019) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2018.12.001 · Cited by 92 · see citing works

Synaptic Loss in Primary Tauopathies Revealed by [ <scp> ¹¹ C </scp> ] <scp>UCB‐J</scp> Positron Emission Tomography

Holland, N., Jones, P. S., Savulich, G., Wiggins, J. K., Hong, Y. T., Fryer, T. D., Manavaki, R., Sephton, S. M., Boros, I., Malpetti, M., et al. (2020) · Movement Disorders · doi:10.1002/mds.28188 · Cited by 93 · see citing works

Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease

Tanner, J. A., Iaccarino, L., Edwards, L., Asken, B. M., Gorno‐Tempini, M. L., Kramer, J. H., Pham, J. Q., Perry, D. C., Possin, K. L., Malpetti, M., et al. (2022) · Brain · doi:10.1093/brain/awac229 · Cited by 88 · see citing works

New Features about Tau Function and Dysfunction

Medina, M., Hernández, F., & Ávila, J. (2016) · Biomolecules · doi:10.3390/biom6020021 · Cited by 92 · see citing works

Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead

Novak, P., Kontsekova, E., Zilka, N., & Novak, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00798 · Cited by 87 · see citing works

EEG alterations during wake and sleep in mild cognitive impairment and Alzheimer's disease

D’Atri, A., Scarpelli, S., Gorgoni, M., Truglia, I., Lauri, G., Cordone, S., Ferrara, M., Marra, C., Rossini, P. M., & Gennaro, L. D. (2021) · iScience · doi:10.1016/j.isci.2021.102386 · Cited by 92 · see citing works

Tau reduction affects excitatory and inhibitory neurons differently, reduces excitation/inhibition ratios, and counteracts network hypersynchrony

Chang, C.-W., Evans, M. D., Yu, X., Yu, G.-Q., & Mucke, L. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109855 · Cited by 81 · see citing works

Amyloid and tau PET demonstrate region-specific associations in normal older people

Lockhart, S. N., Schöll, M., Baker, S. L., Ayakta, N., Swinnerton, K. N., Bell, R. K., Mellinger, T. J., Shah, V. D., O’Neil, J. P., Janabi, M., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.02.051 · Cited by 79 · see citing works

Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model

Shimojo, M., Takuwa, H., Takado, Y., Tokunaga, M., Tsukamoto, S., Minatohara, K., Ono, M., Seki, C., Maeda, J., Urushihata, T., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2880-19.2020 · Cited by 78 · see citing works

Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus

Rodriguez, G. A., Barrett, G., Duff, K., & Hussaini, S. A. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000851 · Cited by 76 · see citing works

Altered Synapse Stability in the Early Stages of Tauopathy

Jackson, J., Witton, J., Johnson, J. D., Ahmed, Z., Ward, M., Randall, A. D., Hutton, M. L., Isaac, J. T. R., O’Neill, M. J., & Ashby, M. C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.013 · Cited by 71 · see citing works

The Sleep Side of Aging and Alzheimer’s Disease

Romanella, S. M., Roe, D., Tatti, E., Cappon, D., Paciorek, R., Testani, E., Rossi, A., Rossi, S., & Santarnecchi, E. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.05.029 · Cited by 69 · see citing works

In vivoimaging reveals reduced activity of neuronal circuits in a mouse tauopathy model

Marinković, P., Blumenstock, S., Goltstein, P. M., Korzhova, V., Peters, F., Knebl, A., & Herms, J. W. (2019) · Brain · doi:10.1093/brain/awz035 · Cited by 63 · see citing works

Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease

Morrone, C. D., Raghuraman, R., Hussaini, S. A., & Yu, W. H. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00617-4 · Cited by 64 · see citing works

Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease

Ossenkoppele, R., & Hansson, O. (2021) · Alzheimer's &amp; Dementia · doi:10.1002/alz.12356 · Cited by 62 · see citing works

Tau neurotoxicity and rescue in animal models of human Tauopathies

Krüger, L., & Mandelkow, E. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.09.004 · Cited by 60 · see citing works

Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease

Khan, A. F., Adewale, Q., Baumeister, T. R., Carbonell, F., Zilles, K., Palomero‐Gallagher, N., Iturria‐Medina, Y., & Initiative, A. D. N. (2021) · Brain · doi:10.1093/brain/awab375 · Cited by 58 · see citing works

Tau and amyloid-related pathologies in the entorhinal cortex have divergent effects in the hippocampal circuit

Angulo, S. L., Orman, R., Neymotin, S. A., Liu, L., Buitrago, L., Cepeda-Prado, E., Stefanov, D. G., Lytton, W. W., Stewart, M., Small, S. A., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.015 · Cited by 56 · see citing works

Tau and β-Amyloid Burden Predict Actigraphy-Measured and Self-Reported Impairment and Misperception of Human Sleep

Winer, J. R., Morehouse, A. B., Fenton, L. E., Harrison, T. M., Ayangma, L., Reed, M. E., Kumar, S., Baker, S. L., Jagust, W. J., & Walker, M. P. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0353-21.2021 · Cited by 52 · see citing works

Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies

Florenzano, F., Corsetti, V., Ciasca, G., Ciotti, M. T., Pittaluga, A., Olivero, G., Feligioni, M., Iannuzzi, F., Latina, V., Sciacca, M. F. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17371 · Cited by 52 · see citing works

Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy

Fjell, A. M., Idland, A., Sala‐Llonch, R., Watne, L. O., Borza, T., Brækhus, A., Lona, T., Zetterberg, H., Blennow, K., Wyller, T. B., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx157 · Cited by 52 · see citing works

Late-in-life neurodegeneration after chronic sleep loss in young adult mice

Owen, J. E., Zhu, Y., Fenik, P., Zhan, G., Bell, P., Liu, X. C., & Veasey, S. C. (2021) · SLEEP · doi:10.1093/sleep/zsab057 · Cited by 48 · see citing works

Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern

Vanderlinden, G., Ceccarini, J., Vande Casteele, T., Michiels, L., Lemmens, R., Triau, E., Serdons, K., Tournoy, J., Koole, M., Vandenbulcke, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01672-x · Cited by 47 · see citing works

Adenosine A 1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280

Dennissen, F. J. A., Anglada‐Huguet, M., Sydow, A., Mandelkow�, E., & Mandelkow, E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603119113 · Cited by 46 · see citing works

Sleep-Based Interventions in Alzheimer’s Disease: Promising Approaches from Prevention to Treatment along the Disease Trajectory

Cordone, S., Scarpelli, S., Alfonsi, V., Gennaro, L. D., & Gorgoni, M. (2021) · Pharmaceuticals · doi:10.3390/ph14040383 · Cited by 49 · see citing works

Theta and gamma oscillatory dynamics in mouse models of Alzheimer’s disease: A path to prospective therapeutic intervention

Mehak, S. F., Shivakumar, A. B., Kumari, S., Muralidharan, B., & Gangadharan, G. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104628 · Cited by 42 · see citing works

The A/T/N model applied through imaging biomarkers in a memory clinic

Dodich, A., Mendes, A., Assal, F., Chicherio, C., Rakotomiaramanana, B., Andryszak, P., Festari, C., Ribaldi, F., Scheffler, M., Schibli, R., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04536-9 · Cited by 42 · see citing works

Amyloid‐β induces sleep fragmentation that is rescued by fatty acid binding proteins in <i>Drosophila</i>

Gerstner, J. R., Lenz, O., Vanderheyden, W. M., Chan, M. T., Pfeiffenberger, C., & Pack, A. I. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23778 · Cited by 40 · see citing works

CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume

Düzel, E., Berron, D., Schütze, H., Cárdenas‐Blanco, A., Metzger, C. D., Betts, M. J., Ziegler, G., Chen, Y., Dobisch, L., Bittner, D., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.10.003 · Cited by 37 · see citing works

Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study

Holland, N., Malpetti, M., Rittman, T., Mak, E. E., Passamonti, L., Kaalund, S. S., Hezemans, F. H., Jones, P. S., Savulich, G., Hong, Y. T., et al. (2022) · Brain · doi:10.1093/brain/awab282 · Cited by 39 · see citing works

Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer’s disease

Deng, Y., Bi, M., Delerue, F., Forrest, S. L., Chan, G., van der Hoven, J., van Hummel, A., Feiten, A., Lee, S., Martínez-Valbuena, I., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02457-w · Cited by 39 · see citing works

Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model

Green, C., Sydow, A., Vogel, S. N., Anglada‐Huguet, M., Wiedermann, D., Mandelkow�, E., Mandelkow, E., & Hoehn, M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0316-6 · Cited by 38 · see citing works

Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration

Holton, C. M., Hanley, N., Shanks, E., Oxley, P., McCarthy, A. P., Eastwood, B. J., Murray, T. K., Nickerson, A. P., & Wafford, K. A. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00651-0 · Cited by 38 · see citing works

Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses

Alves, S. S., da Silva-Júnior, R. M. P., Servilha‐Menezes, G., Homolak, J., Šalković‐Petrišić, M., & Garcia‐Cairasco, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210234 · Cited by 38 · see citing works

Neurophysiological assessment of neural network plasticity and connectivity: Progress towards early functional biomarkers for disease interception therapies in Alzheimer’s disease

Walsh, C., Drinkenburg, W. H. I. M., & Ahnaou, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.020 · Cited by 35 · see citing works

A multi-scale model explains oscillatory slowing and neuronal hyperactivity in Alzheimer’s disease

Alexandersen, C. G., de Haan, W., Bick, C., & Goriely, A. (2023) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0607 · Cited by 36 · see citing works

Spread of pathological human Tau from neurons to oligodendrocytes and loss of high-firing pyramidal neurons in aging mice

Viney, T. J., Sárkány, B., Ozdemir, A. T., Hartwich, K., Schweimer, J. V., Bannerman, D. M., & Somogyi, P. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111646 · Cited by 34 · see citing works

Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases

Wilson, H., Politis, M., Rabiner, E. A., & Middleton, L. T. (2020) · Cells · doi:10.3390/cells9122581 · Cited by 34 · see citing works

Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early‐onset and atypical Alzheimer's disease

Ranasinghe, K. G., Petersen, C., Kudo, K., Mizuiri, D., Rankin, K. P., Rabinovici, G. D., Gorno‐Tempini, M., Seeley, W. W., Spina, S., Miller, B. L., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12349 · Cited by 33 · see citing works

Amyloid pathology but notAPOEε4 status is permissive for tau-related hippocampal dysfunction

Düzel, E., Ziegler, G., Berron, D., Maaß, A., Schütze, H., Cárdenas‐Blanco, A., Glanz, W., Metzger, C. D., Dobisch, L., Reuter, M., et al. (2021) · Brain · doi:10.1093/brain/awab405 · Cited by 30 · see citing works

From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer’s and Parkinson’s diseases

Wakhloo, D., Mahajani, S. U., Oberhauser, J., & Madira, A. E. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.336138 · Cited by 37 · see citing works

Astrocytes restore connectivity and synchronization in dysfunctional cerebellar networks

Kanner, S., Goldin, M. M., Galron, R., Jacob, E. B., Bonifazi, P., & Barzilai, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718582115 · Cited by 32 · see citing works

Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis

Mondragón‐Rodríguez, S., Salgado, H., & Peña‐Ortega, F. (2020) · Neural Plasticity · doi:10.1155/2020/2960343 · Cited by 32 · see citing works

Biomarkers of Alzheimer’s disease in severe obstructive sleep apnea–hypopnea syndrome in the Chinese population

Kong, W., Zheng, Y., Xu, W., Gu, H., & Wu, J. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05948-2 · Cited by 31 · see citing works

Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model

Wang, W., Cao, Q., Tan, T., Yang, F., Williams, J. B., & Yan, Z. (2021) · Aging Cell · doi:10.1111/acel.13456 · Cited by 29 · see citing works

Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy

Trease, A. J., George, J. W., Roland, N. J., Lichter, E. Z., Emanuel, K. M., Totusek, S., Fox, H. S., & Stauch, K. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.852368 · Cited by 30 · see citing works

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum

Pelkmans, W., Ossenkoppele, R., Dicks, E., Strandberg, O. T., Barkhof, F., Tijms, B. M., Pereira, J. B., & Hansson, O. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00876-7 · Cited by 25 · see citing works

Microtubules as Regulators of Neural Network Shape and Function: Focus on Excitability, Plasticity and Memory

Peña‐Ortega, F., Robles-Gómez, Á. A., & Cueva, L. X. (2022) · Cells · doi:10.3390/cells11060923 · Cited by 27 · see citing works

Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature

Przybyla, M., van Eersel, J., van Hummel, A., van der Hoven, J., Sabale, M., Harasta, A. E., Müller, J., Gajwani, M., Prikas, E., Mueller, T., et al. (2020) · Brain · doi:10.1093/brain/awaa133 · Cited by 27 · see citing works

Effect of Aging and a Dual Orexin Receptor Antagonist on Sleep Architecture and Non-REM Oscillations Including an REM Behavior Disorder Phenotype in the PS19 Mouse Model of Tauopathy

Kam, K., Vetter, K., Tejiram, R. A., Pettibone, W. D., Shim, K., Audrain, M., Yu, L., Daehn, I. S., Ehrlich, M. E., & Varga, A. W. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1828-22.2023 · Cited by 25 · see citing works

Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia

Kopach, O., Esteras, N., Wray, S., Rusakov, D. A., & Abramov, A. Y. (2020) · Journal of Cell Science · doi:10.1242/jcs.241687 · Cited by 27 · see citing works

Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia

Kopach, O., Esteras, N., Wray, S., Abramov, A. Y., & Rusakov, D. A. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04007-w · Cited by 26 · see citing works

Synaptic vulnerability to amyloid-β and tau pathologies differentially disrupts emotional and memory neural circuits

Capilla-López, M. D., Deprada-Fernandez, Á., Andrade‐Talavera, Y., Martínez‐Gallego, I., Coatl-Cuaya, H., Sotillo, P. S., Rodrı́guez-Álvarez, J., Moreno, A. R., Parra‐Damas, A., & Saura, C. A. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02901-9 · Cited by 29 · see citing works

Slow and Fast Neocortical Oscillations in the Senescence-Accelerated Mouse Model SAMP8

Castano-Prat, P., Pérez‐Zabalza, M., Perez-Mendez, L., Escorihuela, R. M., & Sanchez-Vives, M. V. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00141 · Cited by 25 · see citing works

Studying Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis with 7-T magnetic resonance

Düzel, E., Costagli, M., Donatelli, G., Speck, O., & Cosottini, M. (2021) · European Radiology Experimental · doi:10.1186/s41747-021-00221-5 · Cited by 28 · see citing works

The Role of miR-128 in Neurodegenerative Diseases

Lanza, M., Cuzzocrea, S., Oddo, S., Esposito, E., & Casili, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076024 · Cited by 25 · see citing works

Molecular imaging of beta-amyloid deposition in late-life depression

Smith, G. S., Kuwabara, H., Nandi, A., Gould, N. F., Nassery, N., Savonenko, A. V., Joo, J. H., Kraut, M. A., Brašić, J. R., Holt, D. P., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.002 · Cited by 25 · see citing works

Tau brings the network down

Bray, N. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn3942

Early impairments of visually-driven neuronal ensemble dynamics in the rTg4510 tauopathy mouse model

Parka, A., Degel, C., Dreyer, J. K., Richter, U., Hall, B. J., Bastlund, J. F., Laursen, B., Nedergaard, M., Sotty, F., & Botta, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106012 · Cited by 4 · see citing works

AlteredIntrinsicPyramidalNeuronPropertiesandPathway- SpecificSynapticDysfunctionUnderlieAberrantHippocampal NetworkFunctioninaMouseModelofTauopathy

Randall, A. D. (2016)

Selective dysfunction of fast-spiking inhibitory interneurons and disruption of perineuronal nets in a tauopathy mouse model

Kudo, T., Takuwa, H., Takahashi, M., Urushihata, T., Shimojo, M., Sampei, K., Yamanaka, M., Tomita, Y., Sahara, N., Suhara, T., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106342 · Cited by 16 · see citing works

Neuronal network activity in the hippocampus of tau transgenic (Tg4510) mice

Scott, L., Kiss, T., Kawabe, T. T., & Hajós, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.002 · Cited by 18 · see citing works